| Toxicology | Lifetime | 9 | FR 1 | 99.27 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 535 | FR 10 | 98.35 |
| Emergency Medicine | Lifetime | 380 | FR 6 | 96.83 |
| Clinical Pharmacology | Lifetime | 776 | FR 9 | 96.49 |
| Pathology and Forensic Medicine | Lifetime | 865 | FR 28 | 95.77 |
| Analytical Chemistry | Lifetime | 431 | FR 8 | 95.34 |
| Spectroscopy and Chemical Instrumentation | Lifetime | 945 | FR 25 | 93.42 |
| Animal Science and Livestock Production | Lifetime | 725 | FR 22 | 93.07 |
| Insect Science | Lifetime | 960 | FR 24 | 83.50 |
| Pharmacology | Lifetime | 920 | FR 15 | 79.80 |
| Anesthesiology and Pain Medicine | Lifetime | 637 | FR 18 | 74.88 |
| Urology | Lifetime | 798 | FR 7 | 68.51 |
| Toxicology | 2021-2025 | 7 | FR 1 | 97.48 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 187 | FR 4 | 96.62 |
| Cell Biology | 2021-2025 | 244 | FR 15 | 74.76 |
| Emergency Medicine | 2021-2025 | 314 | FR 7 | 72.24 |
| Clinical Pharmacology | 2021-2025 | 535 | FR 9 | 65.35 |
| Pathology and Forensic Medicine | 2021-2025 | 589 | FR 18 | 54.79 |
| Forensic Toxicology and Drug Analysis | Lifetime | 21 | FR 1 | 99.32 |
| Analytical Methods in Pharmaceuticals | Lifetime | 66 | FR 2 | 98.79 |
| Pharmacological Effects and Assays | Lifetime | 49 | FR 3 | 98.78 |
| Poisoning and overdose treatments | Lifetime | 36 | FR 2 | 98.85 |
| Hormonal and reproductive studies | Lifetime | 153 | FR 6 | 98.94 |
| Psychedelics and Drug Studies | Lifetime | 42 | FR 1 | 98.18 |
| Metabolomics and Mass Spectrometry Studies | Lifetime | 472 | FR 6 | 97.64 |
| Alcohol Consumption and Health Effects | Lifetime | 265 | FR 7 | 97.85 |
| Veterinary Pharmacology and Anesthesia | Lifetime | 97 | FR 2 | 97.21 |
| Advanced Chemical Sensor Technologies | Lifetime | 723 | FR 11 | 97.49 |
| Cannabis and Cannabinoid Research | Lifetime | 435 | FR 11 | 96.76 |
| Forensic Entomology and Diptera Studies | Lifetime | 171 | FR 6 | 95.01 |
| Pharmacological Receptor Mechanisms and Effects | Lifetime | 409 | FR 16 | 94.32 |
| Pharmacology and Obesity Treatment | Lifetime | 648 | FR 12 | 93.52 |
| Restraint-Related Deaths | Lifetime | 277 | FR 6 | 92.17 |
| Opioid Use Disorder Treatment | Lifetime | 756 | FR 11 | 93.91 |
| Prenatal Substance Exposure Effects | Lifetime | 938 | FR 4 | 90.80 |
| Doping in Sports | Lifetime | 150 | FR 3 | 89.84 |
| Forensic Fingerprint Detection Methods | Lifetime | 379 | FR 3 | 80.33 |
| Paraquat toxicity studies and treatments | Lifetime | 747 | FR 10 | 53.12 |
| Forensic Toxicology and Drug Analysis | 2021-2025 | 15 | FR 1 | 97.51 |
| Hormonal and reproductive studies | 2021-2025 | 51 | FR 2 | 96.85 |
| Doping in Sports | 2021-2025 | 9 | FR 1 | 95.15 |
| Muscle metabolism and nutrition | 2021-2025 | 232 | FR 3 | 91.97 |
| Poisoning and overdose treatments | 2021-2025 | 74 | FR 2 | 91.19 |
| Neurotransmitter Receptor Influence on Behavior | 2021-2025 | 406 | FR 5 | 85.42 |
| Veterinary Pharmacology and Anesthesia | 2021-2025 | 171 | FR 1 | 82.64 |
| Psychedelics and Drug Studies | 2021-2025 | 285 | FR 4 | 83.08 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | 2021-2025 | 348 | FR 3 | 77.98 |
| Pharmacology and Obesity Treatment | 2021-2025 | 647 | FR 3 | 67.46 |
| Pharmacological Effects and Assays | 2021-2025 | 355 | FR 2 | 60.21 |
| Restraint-Related Deaths | 2021-2025 | 520 | FR 15 | 42.22 |
| Forensic Fingerprint Detection Methods | 2021-2025 | 393 | FR 3 | 41.70 |
